¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nonimmunologic hemolytic transfusion reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® transfusion reaction ÇÑ±Û ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ
¼³¸í   
  ¼öÇ÷ÇÏ¿´À» ¶§¿¡ È¯ÀÚ¿¡°Ô ÀϾ´Â ¹ÝÀÀ. ¾Ë·¹¸£±â ¹ÝÀÀ°ú ¿ëÇ÷ ¹ÝÀÀÀÌ ÀÖ´Ù.
¿µ¹® hemolytic disease of newborn ÇÑ±Û ½Å»ý¾Æ¿ëÇ÷º´
¼³¸í   
  ½Å»ý¾Æ¿¡¼­ ÀûÇ÷±¸°¡ ºñÁ¤»óÀûÀ¸·Î ¸¹ÀÌ ÆÄ±«µÇ´Â º´À¸·Î Å¾ÆÀû¸ð±¸Áõ(erythroblastosis fetalis)¿Í °°Àº ¶æÀ¸·Î ¾²ÀδÙ. À̰ÍÀº ¾î¸Ó´Ï¿¡°Ô¼­ »ý»êµÈ ½Å»ý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ Å¹ÝÀ» °Ç³Ê¿Í¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÇÏ¿©¼­ »ý±â´Â ¿ëÇ÷¼ººóÇ÷À» À̸£´Â ¸». ÁŻý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸ÀÇ Ç×ü°¡ ¾î¸Ó´ÏÀÇ ¸ö¿¡¼­ »ý»êÀÌ µÇ°í À̰ÍÀ̠ŹÝÀ» ÅëÇØ¼­ Å¾ƿ¡°Ô ³Ñ¾î°¡¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» Çϰí ÀÌ Ç×ü¿Í °áÇÕÇÑ ÀûÇ÷±¸´Â ÆÄ±«°¡ µÇ¾î¼­ ºóÇ÷ÀÌ »ý±ä °ÍÀ» Å¾ÆÀû¸ð±¸ÁõÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Rh Àû¸ð±¸Áõ(Rh erythroblastosis)¿Í ABO Àû¸ð±¸Áõ(ABO erythroblastosis)·Î ³ª´­ ¼ö°¡ ÀÖ´Ù.
¿µ¹® hemolytic anemia ÇÑ±Û ¿ëÇ÷ºóÇ÷
¼³¸í   
  ¿ëÇ÷ºóÇ÷À̶õ ÀûÇ÷±¸ÀÇ °úµµÇÑ ÆÄ±«¿¡ ÀÇÇÑ ºóÇ÷ÀÌ´Ù. ¿ø·¡ 120ÀÏ Á¤µµÀÇ ¼ö¸íÀ» °¡Áö´Â ÀûÇ÷±¸ÀÇ ¼ö¸íÀ̠ª¾ÆÁö´Â °ÍÀÌ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¿øÀÎÀÌ ÀÖÀ» ¼ö°¡ Àִµ¥ ´ëÇ¥ÀûÀΠ¿øÀÎÀ¸·Î´Â ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ »ý±â´Â °Í(¹ßÀÛ¼º¾ß°£Ç÷»ö¼Ò´¢Áõ)°ú ÀûÇ÷±¸ÀÚüÀÇ ÀÌ»ó(À¯Àü¼ºµÕ±ÙÀûÇ÷±¸Áõ), ±×¸®°í ´Ù¸¥ Áúº´¿¡ ÀÇÇØ¼­ 2Â÷ÀûÀ¸·Î »ý±â´Â °ÍÀÌ ÀÖ´Ù.
¿µ¹® exchange transfusion ÇÑ±Û ±³È¯¼öÇ÷
¼³¸í   
  ÇÑÂÊÀ¸·Î´Â ÇǸ¦ »Ì¾Æ³»¸é¼­ ´Ù¸¥ ÂÊÀ¸·Î´Â °°Àº ¾çÀÇ ÇǸ¦ ³Ö¾î ¿Â¸öÀÇ ÇǸ¦ °¥¾Æ ³Ö´Â ¼öÇ÷¹æ¹ý. °«³­¾ÆÀÌÀÇ ¿ëÇ÷º´ÀÇ Ä¡·á¹ýÀ¸·Î ¾´´Ù.
¿µ¹® transfusion ÇÑ±Û ¼öÇ÷
¼³¸í   
  °Ç°­ÇÑ »ç¶÷¿¡°Ô¼­ Ã¤ÃëÇÑ Ç÷¾×À», Ç÷¾×À̳ª ±× ¼ººÐÀÌ ºÎÁ·ÇѠȯÀÚÀÇ Ç÷°ü ³»¿¡ ÁÖÀÔÇϴ ġ·á ¹æ¹ý. ¼öÇ÷Àº ºóÇ÷ ¶Ç´Â °¢Á¾ ´ë·® ½ÇÇ÷°ú ¼ö¼ú½Ã ÇÇÇÒ ¼ö ¾ø´Â ÃâÇ÷¿¡ ¹Ýµå½Ã ÇÊ¿äÇÑ ±¸¸íóġ·Î¼­ È¯ÀÚÀÇ Ç÷¾×Çü¿¡ ÀûÇÕÇÑ ¾çÁúÀÇ Ç÷¾×ÀÌ ¿ä±¸µÈ´Ù. ¼öÇ÷Àº º¸Åë ÀüÇ÷À» Á¤¸Æ ³»¿¡ ÁÖÀÔÇÏÁö¸¸, ¶§·Î´Â °ñ¼ö ³» ¶Ç´Â µ¿¸Æ ³»¿¡ ¼öÇ÷ÇÒ ¶§µµ ÀÖ´Ù. ¼öÇ÷Çϴ Ç÷¾×µµ ÀüÇ÷ÀÌ ¾Æ´Ñ ¾×»ó ¼ººÐÀΠ³ÃÀ堶Ǵ ³Ãµ¿Ç÷ÀåÀ» »ç¿ëÇÒ ¼ö ÀÖ°í, ÀûÇ÷±¸³ª ¹éÇ÷±¸-Ç÷¼ÒÆÇ°ú °°Àº ¼¼Æ÷¼ººÐÀ» ¿ø½ÉºÐ¸®ÇÏ¿© ±ÍÁßÇÑ Ç÷¾×À» ´õ ¾Æ³¢°í ´õ È¿°úÀûÀ¸·Î ¾²°í ÀÖ´Ù. ¼öÇ÷ÀÇ È¿°ú´Â ¼øÈ¯Ç÷¾×·®À» º¸ÃæÇÏ¿© Ç÷¾ÐÀ» À¯ÁöÇϰí, ºÎÁ·ÇÑ °¢Á¾ Ç÷¾×¼ººÐÀ» °ø±Þ Á¶Á¤Çϸç, Á¶Ç÷±â´ÉÀ» ÀÚ±ØÇϴ ÀÏ µîÀ» µé ¼ö ÀÖ´Ù. ±ä±ÞÇÑ ¼öÇ÷ÀÇ ´ë»óÀº ±³Åë»ç°í µî ¿Ü»ó¿¡ ÀÇÇÑ ´ëÃâÇ÷°ú À§±Ë¾ç-ÀڱÿÜÀӽŠµî¿¡ µû¸£´Â º´Àû ÃâÇ÷°ú °¢Á¾ Ç÷¾×Áúȯ¿¡ ¼ö¹ÝµÇ´Â ºóÇ÷°ú ¹éÇ÷±¸ ¹× Ç÷¼ÒÆÇ °¨¼Ò, ±×¸®°í Ç÷¿ìº´ È¯ÀÚ³ª ´Ù¸¥ È¯ÀÚ¿¡¼­ º¼ ¼ö Àִ Ç÷¾×ÀÀ°íÀÎÀÚ ºÎÁ·°ú È­»óȯÀÚ-°£Áúȯ µî¿¡¼­ ºÎÁ·ÇØÁø Ç÷À堶Ǵ ¾ËºÎ¹ÎÀÇ º¸Ãæ°ú ¸é¿ªÃ¼°¡ ºÎÁ·ÇÏ¿© °¨¿°ÁõÀÌ »ý±ä È¯ÀÚ¿¡°Ô ºÎÁ·ÇÑ Ç×ü¸¦ Æ÷ÇÔÇÑ Ç÷¾× ¶Ç´Â Ç÷ÀåÁ¦Á¦¸¦ Áִ °Íµµ ÀÌ¿¡ ¼ÓÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonimmunologic hemolytic transfusion reaction
    ºñ¸é¿ª¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonimmunologic febrile transfusion reaction
    ºñ¸é¿ª¹ß¿­¼º¼öÇ÷¹ÝÀÀ
  • nonimmunologic nonhemolytic transfusion reaction
    ºñ¸é¿ªºñ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • delayed hemolytic transfusion reaction
    Áö¿¬¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • hemolytic transfusion reaction
    ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • blood transfusion reaction
    ¼öÇ÷¹ÝÀÀ
  • febrile transfusion reaction
    ¹ß¿­¼º¼öÇ÷¹ÝÀÀ
  • autologous transfusion
    ÀÚ°¡¼öÇ÷
  • component transfusion
    ¼ººÐ¼öÇ÷
  • cryoprecipitate transfusion
    µ¿°áħÀüÁ¦Á¦¼öÇ÷
  • direct transfusion
    Á÷Á¢¼öÇ÷
  • exchange transfusion
    ±³È¯¼öÇ÷
  • fetomaternal transfusion
    žƸðü¼öÇ÷
  • fetus to fetus transfusion
    žƻçÀ̼öÇ÷
  • immediate transfusion
    Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transfusion reaction
    ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ
  • hemolytic anemia
    ¿ëÇ÷ºóÇ÷
  • hemolytic uremic syndrome
    ¿ëÇ÷¿äµ¶ÁõÈıº
  • transfusion
    ¼öÇ÷
  • autologous transfusion
    (¢¡autotransfusion) ÀÚ°¡¼öÇ÷
  • cryoprecipitate transfusion
    µ¿°áħÀüÁ¦Á¦¼öÇ÷
  • exchange transfusion
    ±³È¯¼öÇ÷
  • feto-maternal transfusion
    žƸðü¼öÇ÷
  • fetus to fetus transfusion
    ½ÖžƻçÀ̼öÇ÷
  • massive transfusion
    ´ë·®¼öÇ÷
  • substitution transfusion
    (¢¡exchange transfusion) ±³È¯¼öÇ÷
  • reaction formation
    ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
  • reaction fever
    ¹ÝÀÀ¿­
  • reaction
    ¹ÝÀÀ
  • adjustment reaction
    ÀûÀÀ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonimmunologic hemolytic transfusion reaction
    ºñ¸é¿ª¿ëÇ÷¼öÇ÷ºÎÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonimmunologic febrile transfusion reaction
    ºñ¸é¿ª¹ß¿­¼öÇ÷ºÎÀÛ¿ë
  • nonimmunologic nonhemolytic transfusion reaction
    ºñ¸é¿ªºñ¿ëÇ÷¼öÇ÷ºÎÀÛ¿ë
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼öÇ÷¹ÝÀÀ
  • delayed hemolytic transfusion reaction
    Áö¿¬¿ëÇ÷¼öÇ÷ºÎÀÛ¿ë
  • hemolytic transfusion reaction
    ¿ëÇ÷¼öÇ÷¹ÝÀÀ
  • blood transfusion reaction
    ¼öÇ÷¹ÝÀÀ
  • febrile transfusion reaction
    ¹ß¿­¼öÇ÷ºÎÀÛ¿ë
  • transfusion reaction
    ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ
  • autologous transfusion
    (¢¡autotransfusion) ÀÚ°¡¼öÇ÷
  • bone marrow transfusion
    °ñ¼ö¼öÇ÷
  • component transfusion
    ¼ººÐ¼öÇ÷
  • cryoprecipitate transfusion
    µ¿°áħÀüÁ¦Á¦¼öÇ÷
  • direct transfusion
    (¢¡immediate transfusion) Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
  • exchange transfusion
    ±³È¯¼öÇ÷
  • exsanguination transfusion
    (¢¡exchange transfusion) ±³È¯¼öÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • hemolytic transfusion reaction
    ¿ëÇ÷¼º ¼öÇ÷¹ÝÀÀ.
  • Hemolytic transfusion reactions
    ¿ëÇ÷¼º ¼öÇ÷¹ÝÀÀ(âÃúìÚãëë)
  • hemolytic transfusion reactions
    ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • granulocyte transfusion
    °ú¸³¼¼Æ÷ ¼öÇ÷
  • immune serum globulin transfusion
    ¸é¿ªÇ÷û±Û·ÎºÒ¸°¼öÇ÷
  • incompatible blood transfusion
    ºÎÀûÇÕ ¼öÇ÷.
  • indirect transfusion
    °£Á¢¼öÇ÷.
  • plasma component transfusion
    Ç÷À强ºÐ¼öÇ÷
  • platelet transfusion
    Ç÷¼ÒÆÇ¼öÇ÷(¡­âÃúì).
  • platelet transfusion
    Ç÷¼ÒÆÇ¼öÇ÷
  • post transfusion hepatitis
    ¼öÇ÷Èİ£¿°.
  • post transfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ(âÃúìý­í¹Úèñø)
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • pre-transfusion testing
    ¼öÇ÷Àü°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonimmunologic hemolytic transfusion reactions
    ºñ¸é¿ª¼º¿ëÇ÷¼öÇ÷¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonimmunologic febrile transfusion reactions
    ºñ¸é¿ª¼º ¹ß¿­¼öÇ÷¹ÝÀÀ
  • nonimmunologic nonhemolytic transfusion rections
    ºñ¸é¿ª¼ººñ¿ëÇ÷¼öÇ÷¹Ý ÀÀ
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • hemolytic transfusion reaction
    ¿ëÇ÷¼º ¼öÇ÷¹ÝÀÀ.
  • delayed hemolytic transfusion reactions
    Áö¿¬¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • hemolytic transfusion reactions
    ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • blood transfusion reaction
    ¼öÇ÷ºÎÀÛ¿ë.
  • febrile transfusion reaction
    ¹ß¿­¼º ¼öÇ÷¹ÝÀÀ
  • transfusion reaction
    ¼öÇ÷ºÎÀÛ¿ë
  • transfusion reaction
    ¼öÇ÷ÀÛ¿ë
  • transfusion reaction
    ¼öÇ÷ÀÛ¿ë(¡­íÂéÄ)
  • transfusion reaction
    ¼öÇ÷ÀÛ¿ë(¡­íÂéÄ).
  • transfusion reaction investigation
    ¼öÇ÷ÀÛ¿ëÁ¶»ç
  • pas reaction ; periodic acld schiff reaction
    PAS ¹ÝÀÀ<¿°»ö>(¡­Úãëë<æøßä>)
  • untoward effect =adverse reaction, unwanted reaction
    À¯ÇعÝÀÀ(êóúªÚãëë), ºÎÀÛ¿ë
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Immune cause (Hemolytic anemia)
    ¸é¿ª¿øÀÎ(¿ëÇ÷¼ººóÇ÷)
    [¿¾ ¿ë¾î] ¸é¿ª¼º¿øÀÎ
  • Reaction deficiency
    ¹ÝÀÀ°áÇÌ
    [¿¾ ¿ë¾î] ¹ÝÀÀ°áÇÌ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired hemolytic anemia
    "ȹµæ¿ëÇ÷¼ººóÇ÷ (üòÔðéÁúìàõÞ¸úì), ÈÄõ¿ëÇ÷¼ººóÇ÷ (ý­ô¸éÁúìàõÞ¸úì)"
  • hemolytic anemia
    ¿ëÇ÷ ºóÇ÷(éÁúìÞ¸úì)
  • hemolytic antibody
    ¿ëÇ÷ Ç×ü(éÁúìù÷ô÷)
  • hemolytic immune body
    ¿ëÇ÷ ¸é¿ªÃ¼(éÁúìØóæ¹ô÷)
  • hemolytic plaque assay
    ¿ëÇ÷(éÁúì) ÇöóÅ© ¾Æ½êÀÌ
  • median hemolytic dose
    Á¤Áß ¿ëÇü·®(ïáñééÁúìÕá)
  • minimum hemolytic dose
    ÃÖ¼Ò¿ëÇ÷·®(õÌá³éÁúìÕá)
  • absolute reaction rates
    Àý´ë¹ÝÀÀ¼Óµµ (ï¾ÓßÚãëëáÜÓø)
  • abstraction reaction
    Á¦°Å¹ÝÀÀ (ð¶ËÛÚãëë)
  • Adamkiewicz reaction
    ¾Æ´ãŰºñÃ÷ ¹ÝÀÀ(Úãëë)
  • addition reaction
    ºÎ°¡¹ÝÀÀ(ݾʥÚãëë)
  • Akabori reaction
    ¾ÆÄ«º¸¸®¹ÝÀÀ(Úãëë)
  • alarm reaction
    °æÁ¾¹ÝÀÀ (Ìíñ¤Úãëë)
  • anaphylactoid reaction
    ¾Æ³ªÇʶô½Ã½º¾ç(åÆ) ¹ÝÀÀ(Úãëë)
  • anaplerotic reaction
    º¸Àü¹ÝÀÀ(ÜÍîóÚãëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transfusion
    ¼öÇ÷, ¼ö¾×
  • hemolytic anemia
    ¿ëÇ÷¼ººóÇ÷
  • hemolytic jaundice
    ¿ëÇ÷¼ºÈ²´Þ
  • hemolytic streptococcal infection
    ¿ëÇ÷¼º¿¬¼â±¸±Õ°¨¿°
  • adverse reaction
    ºÎÀÛ¿ë, À¯ÇعÝÀÀ, À¯ÇØÀÛ¿ë, ¿ª¹ÝÀÀ
  • antigen antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • desmoid reaction
    Àδë¾ç¹ÝÀÀ
  • glial reaction
    ±³¼¼Æ÷ÀÛ¿ë,½Å°æ±³ÀÛ¿ë
  • hypersensitive reaction
    °ú¹Î¼º¹ÝÀÀ
  • leukemoid reaction
    ¹éÇ÷º´¾ç ¹ÝÀÀ
  • periosteal reaction
    °ñ¸·¹ÝÀÀ
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ
  • reaction
    ¹ÝÀÀ
  • side reaction
    ºÎÀÛ¿ë, ºÎ¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AHA acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;...
MHD maintenance hemodialysis; mean hemolytic dose; mental health department; minimum hemolytic dilution;...
PTR patellar tendon reflex; patient termination record; patient to return; peripheral total resistance; ...
NICU neonatal intensive care unit; neurological intensive care unit; neurosurgical intensive care unit; n...
IHBT incompatible hemolytic blood transfusion
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DHTR Delayed hemolytic transfusion reaction
HTR Hemolytic transfusion reactions
BHS Beta-hemolytic streptococci
CH 50 Complement hemolytic activity
GABHS Group A beta hemolytic streptococcal
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute hemolytic transfusion reaction
    ±Þ¼º ¿ëÇ÷¼º ¼öÇ÷ ¹ÝÀÀ
  • autologous transfusion
    ÀÚ°¡ ¼öÇ÷, ÀÚ°¡ ¼öÇ÷¹ý
  • blood transfusion
    ¼öÇ÷
    Ç÷¾×¿¡ Ç×ÀÀ°íÁ¦¸¦ ÷°¡ÇÑ °ÍÀ» Á¤¸Æ³»¿¡ ÁÖ»çÇÏ´Â °ÍÀ» ¸»Çϸç, º¸Åë ´Ù¸¥ »ç¶÷À¸·ÎºÎÅÍ Ã¤Ç÷ÇÑ °ÍÀ» ¼öÇ÷ÇÑ´Ù.
  • bone-marrow blood transfusion
    °ñ¼ö ¼öÇ÷
    °æ°ñ°ú Èä°ñÀÇ °ñ¼ö¿¡ Ç÷¾×À» ÁÖÀÔÇÏ´Â ¼öÇ÷ÀÇ º¯¹ý. Ç×»ó ¾²´Â Á¤¸Æ ³» ¼öÇ÷·Î´Â °¨¼ö¼ºÀÌ Áö³ªÄ¡°Ô °­Çϰųª ¸öÀÌ ºñ¸¸ÇÏ¿© Á¤¸ÆÀ» ã±â ¾î·Á¿î ȯÀÚ ¶Ç´Â À¯¾Æ¸¦ ´ë»óÀ¸·Î ÇÒ °æ¿ì ÀÌ ¹æ¹ýÀ¸·Î ¼öÇ÷ÇÒ ¶§°¡ ÀÖ´Ù. ¶Ç ¹éÇ÷º´À̳ª Àç»ýºÒ·®¼º ºóÇ÷ ȯÀÚ¿¡°Ô´Â ÀÌ ¹æ¹ýÀÌ Á¤¸Æ ¼öÇ÷º¸´Ù ¶Ù¾î³­ È¿°ú°¡ ÀÖ´Ù´Â °ßÇØµµ ÀÖ´Ù. ¹æ¹ýÀº °ñ¼ö õÀÚ¸¦ ÇÏ¿© Á¡Àû ÀåÄ¡ ¶Ç´Â ´ëÇü ÁÖ»ç±â·Î äÇ÷ÇÑ Ç÷¾×À» °ñ¼ö ³»¿¡ ÁÖÀÔÇÑ´Ù. ´Ù·® ¼öÇ÷ÀÌ °¡´ÉÇÏÁö¸¸, ±¹ºÎ ÇÇºÎ¿Í °ñ¸·¿¡ ±¹¼Ò¸¶Ã븦 ÇØ¾ß ÇÒ Çʿ䰡 ÀÖ´Ù. ±×¸®°í Á¤¸Æ ¼öÇ÷º¸´Ù ½Ã°£ÀÌ °É¸®°í ¼¼½ÉÇÑ ÁÖÀǰ¡ ÇÊ¿äÇϸç, ȯÀÚ¿¡°Ô °íÅëÀ» Áְųª, ³Ê¹« »¡¸® ÁÖÀÔÇÏ¸é ±¹¼Ò¿¡ ÅëÁõÀ» ÁÖ´Â µîÀÇ °áÁ¡ÀÌ ÀÖ´Ù.
  • component transfusion
    ¼ººÐ ¼öÇ÷
    ÀüÇ÷
  • exchange transfusion
    ±³È¯ ¼öÇ÷
    ȯÀÚÀÇ ÀüÇ÷¾×À» °øÇ÷ÀÚÀÇ Ç÷¾×À¸·Î ġȯÇÏ´Â ¹æ¹ýÀÌ¸ç ½Å»ý¾ÆÀÇ ¿ëÇ÷¼º ºóÇ÷ µî¿¡ »ç¿ëµÈ´Ù.
  • immediate transfusion
    Á÷Á¢ ¼öÇ÷, Áï°¢ ¼öÇ÷, Áï½Ã ¼öÇ÷
    Áß°£ ¿ë±â³ª Ç×ÀÀ°íÁ¦¸¦ »ç¿ëÇÏÁö ¾Ê°í, ¾î¶² »ç¶÷À¸·ÎºÎÅÍ ´Ù¸¥ »ç¶÷¿¡°Ô·Î Ç÷¾×À» Á÷Á¢ ¿Å±â´Â °Í.
  • incompatible blood transfusion
    ºÎÀûÇÕ ¼öÇ÷
  • malaria transfusion
    ¼öÇ÷ ¸»¶ó¸®¾Æ
    ¿À¿°µÈ ÁÖ»ç ¹Ù´ÃÀÇ ¿ì¹ßÀû °¨¿°À̳ª, ÁÖ»ç ¹Ù´ÃÀ» °øµ¿À¸·Î »ç¿ëÇÏ´Â ¾à¹° Ž´ÐÀÚ¿¡ ÀÇÇØ¼­ °øÇ÷ÀڷκÎÅÍ Á÷Á¢ ÀüÆÄµÇ´Â Plasmodium malariae, Plasmodium vivax, Plasmodium ovaleÀÇ °¨¿°.
  • platelet transfusion
    Ç÷¼ÒÆÇ ¼öÇ÷
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄ Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • serum transfusion
    Ç÷û ¼öÇ÷
  • transfusion
    ¼öÇ÷, ¼ö¾×
    ÀüÇ÷À̳ª Ç÷¾× ¼ººÐÀÌ Ç÷·ù·Î Á÷Á¢ µé¾î°¡´Â °Í.
  • transfusion procedure
    ¼öÇ÷ óġ
  • white blood cell transfusion
    ¹éÇ÷±¸ ¼öÇ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
hemolytic anaemia <disease, haematology> Anaemia resulting from reduced red cell survival time and haemolysis, either due to an intrinsic defect in the erythrocyte (hereditary spherocytosis or ellipsocytosis, enzyme defects, haemoglobinopathy) or an extrinsic damaging agent.
For example autoantibody (autoimmune haemolytic anaemia), iso antibody, parasitic invasion of the cells (malaria), bacterial or chemical haemolysins, mechanical damage to erythrocytes.
Origin: Gr. Haima = blood
(18 Nov 1997)
blood transfusion reaction This refers to an immune response against transfused blood cells. Antigens, on the surface of red blood cells, are recognised as foreign proteins and can stimulate sensitised lymphocytes to produce antibodies to the red blood cell antigens. This triggers a complex immunological reaction that results in the destruction of the transfused red blood cell. The blood groups (A, B, AB, O) are classified on the basis of the presence of surface antigens on the red blood cell. Type A blood has A antigens. The plasma component of the blood contains the antibodies against all other blood group antigens other that its own. Another type of surface antigen is known as Rh factor. Rh factor is either present (Rh positive) or absent (Rh negative). Rh compatibility is another requirement for blood transfusion.
Symptoms and findings of a transfusion reaction include flank pain, fever, chills, bloody urine, rash, low blood pressure, dizziness and fainting.
(27 Sep 1997)
incompatible blood transfusion reaction A syndrome due to intravascular haemolysis of transfused blood by serum antibodies of the recipient, which react with an antigen of the donor red cells; characterised by chills, fever (often with urticaria), backache or muscle cramps, haemoglobinaemia, haemoglobinuria, and oliguria, which may result in acute renal failure, DIC, and death.
(05 Mar 2000)
transfusion reaction A reaction to a blood transfusion secondary to some incompatibility in type, RH factor or other surface antigens. May be manifest by haemolytic anaemia, heart failure, and-or renal failure.
Symptoms include facial flushing, angioedema, headache, wheezing, anaphylaxis, shock, fever, chills and breathing difficulty.
(27 Sep 1997)
arterial transfusion Direct transfusion from an artery of the donor into an artery of the receptor.
(05 Mar 2000)
blood component transfusion The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in plasmapheresis and types of cytapheresis (plateletpheresis and leukapheresis) where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor.
(12 Dec 1998)
blood transfusion The process of infusing blood products into a patient to raise the individuals concentration of red blood cells. Blood is typed (A, B, O or AB) and crossmatched (mixed together to see if its compatible) prior to transfusion.
(27 Sep 1997)
blood transfusion, autologous Reinfusion of blood or blood products derived from the patient's own circulation.
(12 Dec 1998)
blood transfusion, intrauterine Transfusion of rh-negative blood into the peritoneal cavity of an unborn infant in the treatment of foetal erythroblastosis (erythroblastosis, foetal) in utero.
(12 Dec 1998)
reciprocal transfusion An attempt to confer immunity by transfusing blood taken from a donor into a receiver suffering from the same affection, the balance being maintained by transfusing an equal amount from the receiver to the donor.
(05 Mar 2000)
mediate transfusion Transfusion into a patient of blood previously obtained from a donor and stored in a suitable container.
Synonym: mediate transfusion.
(05 Mar 2000)
peritoneal transfusion The injection of saline solution or other fluid into the peritoneal cavity.
(05 Mar 2000)
placental transfusion Return to the newborn via the umbilical vessels some of the foetal placental blood.
(05 Mar 2000)
platelet transfusion The transfer of blood platelets from a donor to a recipient or reinfusion to the donor.
(12 Dec 1998)
subcutaneous transfusion An infusion of absorbable solutions beneath the skin.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transfusion
    ºÎ¾î ³Ö±â
  • hemolytic
    ¿ëÇ÷(¼º)ÀÇ
  • reaction
    ¹Ýµ¿
  • Feulgen reaction
    Æ÷ÀϰÕ(ÇÙ¿°»ö)¹ÝÀÀ
  • GVH reaction
    ´ë¼÷ÁÖ ÀÌ½ÄÆí ¹ÝÀÀ(ÀÌ½ÄµÈ Àå±â¿Í ü³» ¸é¿ª ¼¼Æ÷°£ÀÇ ¹ÝÀÀ)
  • atomic reaction
    ¿øÇÙ ¹ÝÀÀ
  • atonic reaction
    ¿øÀÚÇÙ¹ÝÀÀ
  • chain reaction
    ¿¬¼â ¹ÝÀÀ;(»ç°Ç µîÀÇ)¿¬¼â ¹ÝÀÀ
  • dark reaction
    (½Ä)¾Ï¹ÝÀÀ
  • exchange reaction
    (¹°)±³È¯ ¹ÝÀÀ
  • fightorfight reaction
    ¹æÀ§ ¹ÝÀÀÀÇ ÀÏÁ¾
  • fission chain reaction
    Çٺп­ ¿¬¼â ¹ÝÀÀ
  • fusion reaction
    ÇÙÀ¶ÇÕ ¹ÝÀÀ
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • protective reaction
    ¹æ¾î ¹ÝÀÀ(ÀÚÀ§,º¸º¹À» ¸ñÀûÀ¸·Î ÇÑ Æø°Ý)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á